{"id":293482,"date":"2020-12-11T06:28:50","date_gmt":"2020-12-10T19:28:50","guid":{"rendered":"https:\/\/www.gomarketingteam.com\/articles\/vaccine-updates-brexit-eu-budget-and-ipos\/"},"modified":"2021-02-19T12:13:02","modified_gmt":"2021-02-19T01:13:02","slug":"vaccine-updates-brexit-eu-budget-and-ipos","status":"publish","type":"post","link":"https:\/\/www.gomarkets.com\/en\/weekly-summaries\/vaccine-updates-brexit-eu-budget-and-ipos\/","title":{"rendered":"Vaccine updates, Brexit, EU budget and IPOs"},"content":{"rendered":"

By Deepta Bolaky<\/strong>
\n\u00a0@DeeptaGOMarkets<\/a><\/p>\n

As we progressed through the last month of the year, investors assessed the vaccine updates, Brexit negotiations, US political gridlock and geopolitical tensions. <\/span><\/p>\n

Stock market –\u00a0 vaccine updates, Brexit and IPOs<\/b><\/h4>\n

Global equities swung between losses and gains this week as investors digested contradictory headlines on key themes driving the price action in the markets.\u00a0<\/span><\/p>\n

\"\"
\nSource: Bloomberg<\/p>\n

Brexit <\/b>negotiations have been dominating headlines throughout the week ahead of the looming year-end deadline. Investors were taken on a roller-coaster ride following intensifying deal negotiations and on-and-off positive and negative announcements. A joint statement by European Commission resident Ursula von der Leyen and UK Prime Minister Boris Johnson set a sour but hopeful tone to negotiations:<\/span><\/p>\n

\u201cAs agreed on Saturday, we took stock today of the ongoing negotiations, We agreed that the conditions for finalising an agreement are not there due to the remaining significant differences on three critical issues: <\/span><\/i>level playing field<\/i><\/b>, <\/span><\/i>governance<\/i><\/b> and <\/span><\/i>fisheries<\/i><\/b>. We asked our Chief Negotiators and their teams to prepare an overview of the remaining differences to be discussed in a physical meeting in Brussels in the coming days.\u201d<\/span><\/i><\/p>\n

The meeting in Brussels and the announcement of an \u201c<\/span>agreement in principle<\/b>\u201d renewed hopes of a deal just in time. However, as the week comes to an end, the \u201cno-deal\u201d Brexit scenario creep back into markets:<\/span><\/p>\n

\u201cRelations with the UK: Commission proposes targeted contingency measures to prepare for possible \u201cno-deal\u201d scenario.\u201d<\/b><\/p>\n

\"\"<\/p>\n

EU Budget: <\/b>On the other side, the European Union is set to move ahead with the agreement on the \u20ac1.8tn seven-year EU budget and recovery fund as Poland and Hungary lift their objections at a summit at Brussels.\u00a0<\/span><\/p>\n

Vaccine updates:<\/b><\/h5>\n

Pfizer and BioNtech<\/b> confirmed on Thursday that the FDA advisory committee voted in support of the potential first emergency use authorisation for the use of the vaccine in the US<\/span>:<\/b><\/p>\n